(Q38304391)

1 September 2017

Role of signal transducer and activator of transcription 3 in liver fibrosis progression in chronic hepatitis C-infected patients (English)

1 reference

1 September 2017

1 reference

Peter Stärkel

1

1 reference

1 September 2017

Christine De Saeger

series ordinal

2

1 reference

1 September 2017

Isabelle Leclercq

series ordinal

3

1 reference

1 September 2017

Yves Horsmans

series ordinal

4

1 reference

1 September 2017

27 November 2006

1 reference

1 September 2017

Laboratory Investigation

1 reference

1 September 2017

87

1 reference

1 September 2017

2

1 reference

1 September 2017

173-181

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3700496

1 September 2017

0 references

cites work

Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Microarray analyses and molecular profiling of Stat3 signaling pathway induced by hepatitis C virus core protein in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Insights into the Pathobiology of Hepatitis C Virus-Associated Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Relationship between apoptosis, tumour necrosis factor, and cell proliferation in chronic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Hepatoprotection via the IL-6/Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Transcription factors in liver development, differentiation, and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

The molecular physiology of liver regeneration following partial hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Deficient Stat3 DNA-binding is associated with high Pias3 expression and a positive anti-apoptotic balance in human end-stage alcoholic and hepatitis C cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Retrorsine: a kinetic study of its influence on rat liver regeneration in the portal branch ligation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Specific inhibition of Stat3 signal transduction by PIAS3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Negative regulation of cytokine signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

The hepatitis C virus replicon system: from basic research to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

Apoptosis and apoptosis related proteins in chronic viral liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

7 January 2021

Chronic hepatitis. An update on terminology and reporting.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

7 January 2021

Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

7 January 2021

IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

7 January 2021

Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700496

7 January 2021

10.1038/LABINVEST.3700496

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

1 reference